| Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs AAM Van der Veldt, M Lubberink, I Bahce, M Walraven, MP de Boer, ... Cancer cell 21 (1), 82-91, 2012 | 370 | 2012 |
| Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and … LJ Rijzewijk, RW van der Meer, HJ Lamb, HWAM de Jong, M Lubberink, ... Journal of the American College of Cardiology 54 (16), 1524-1532, 2009 | 348 | 2009 |
| Blood–brain barrier P-glycoprotein function in Alzheimer's disease DME van Assema, M Lubberink, M Bauer, WM van der Flier, RC Schuit, ... Brain 135 (1), 181-189, 2012 | 342 | 2012 |
| Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment M Sandström, U Garske-Román, D Granberg, S Johansson, C Widström, ... Journal of Nuclear Medicine 54 (1), 33-41, 2013 | 291 | 2013 |
| Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in … RW van der Meer, LJ Rijzewijk, HWAM de Jong, HJ Lamb, M Lubberink, ... Circulation 119 (15), 2069-2077, 2009 | 272 | 2009 |
| First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule J Sörensen, D Sandberg, M Sandström, A Wennborg, J Feldwisch, ... Journal of nuclear medicine 55 (5), 730-735, 2014 | 270 | 2014 |
| Measuring HER2-receptor expression in metastatic breast cancer using [68Ga] ABY-025 Affibody PET/CT J Sörensen, I Velikyan, D Sandberg, A Wennborg, J Feldwisch, ... Theranostics 6 (2), 262, 2016 | 262 | 2016 |
| In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET G Antoni, M Lubberink, S Estrada, J Axelsson, K Carlson, L Lindsjö, ... Journal of Nuclear Medicine 54 (2), 213-220, 2013 | 250 | 2013 |
| Studies of a next-generation silicon-photomultiplier–based time-of-flight PET/CT system DFC Hsu, E Ilan, WT Peterson, J Uribe, M Lubberink, CS Levin Journal of Nuclear Medicine 58 (9), 1511-1518, 2017 | 242 | 2017 |
| Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE E Ilan, M Sandström, C Wassberg, A Sundin, U Garske–Román, ... Journal of nuclear medicine 56 (2), 177-182, 2015 | 240 | 2015 |
| Effect of age on functional P‐glycoprotein in the blood‐brain barrier measured by use of (R)‐[11C]verapamil and positron emission tomography R Toornvliet, BNM van Berckel, G Luurtsema, M Lubberink, AA Geldof, ... Clinical Pharmacology & Therapeutics 79 (6), 540-548, 2006 | 224 | 2006 |
| Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET CS van der Vos, D Koopman, S Rijnsdorp, AJ Arends, R Boellaard, ... European journal of nuclear medicine and molecular imaging 44, 4-16, 2017 | 205 | 2017 |
| Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification I Velikyan, A Sundin, J Sörensen, M Lubberink, M Sandström, ... Journal of Nuclear Medicine 55 (2), 204-210, 2014 | 200 | 2014 |
| Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial F Rosqvist, J Kullberg, M Ståhlman, J Cedernaes, K Heurling, ... The Journal of Clinical Endocrinology & Metabolism 104 (12), 6207-6219, 2019 | 182 | 2019 |
| Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors M Sandström, I Velikyan, U Garske-Román, J Sörensen, B Eriksson, ... Journal of Nuclear Medicine 54 (10), 1755-1759, 2013 | 168 | 2013 |
| P-glycoprotein function at the blood–brain barrier: effects of age and gender DME van Assema, M Lubberink, R Boellaard, RC Schuit, AD Windhorst, ... Molecular imaging and biology 14, 771-776, 2012 | 162 | 2012 |
| Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner HJ Harms, P Knaapen, S de Haan, R Halbmeijer, AA Lammertsma, ... European journal of nuclear medicine and molecular imaging 38, 930-939, 2011 | 160 | 2011 |
| Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia M Dewey, M Siebes, M Kachelrieß, KF Kofoed, P Maurovich-Horvat, ... Nature Reviews Cardiology 17 (7), 427-450, 2020 | 158 | 2020 |
| Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes LJ Rijzewijk, JT Jonker, RW van der Meer, M Lubberink, HW de Jong, ... Journal of the American College of Cardiology 56 (3), 225-233, 2010 | 152 | 2010 |
| Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm K Chiotis, L Saint-Aubert, I Savitcheva, V Jelic, P Andersen, M Jonasson, ... European journal of nuclear medicine and molecular imaging 43 (9), 1686-1699, 2016 | 150 | 2016 |
Ronald BoellaardProfessor Clinical Physics of Positron Emission Tomography, VUmc, Amsterdam在 vumc.nl 的电子邮件经过验证
